HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8 | -20.0% | 10,564 | -67.3% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 32,289 | +61.7% | 0.00% | – |
| Q3 2022 | $10,000 | +42.9% | 19,966 | +71.4% | 0.00% | – |
| Q2 2022 | $7,000 | +250.0% | 11,648 | +519.6% | 0.00% | – |
| Q1 2022 | $2,000 | -71.4% | 1,880 | -45.0% | 0.00% | – |
| Q2 2021 | $7,000 | -84.8% | 3,418 | -86.5% | 0.00% | -100.0% |
| Q1 2021 | $46,000 | +228.6% | 25,308 | +460.0% | 0.00% | – |
| Q3 2020 | $14,000 | – | 4,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 923,230 | $2,022,000 | 0.82% |
| Worth Venture Partners, LLC | 233,947 | $512,000 | 0.40% |
| PERKINS CAPITAL MANAGEMENT INC | 150,000 | $329,000 | 0.22% |
| GSA CAPITAL PARTNERS LLP | 89,067 | $195,000 | 0.03% |
| PREMIER ASSET MANAGEMENT LLC | 70,000 | $153,000 | 0.03% |
| Allen Capital Group, LLC | 23,685 | $52,000 | 0.01% |
| ZEKE CAPITAL ADVISORS, LLC | 50,000 | $110,000 | 0.01% |
| Prospera Financial Services Inc | 39,300 | $86,000 | 0.01% |
| Onex Canada Asset Management Inc. | 20,000 | $44,000 | 0.00% |
| Schonfeld Strategic Advisors LLC | 95,300 | $208,000 | 0.00% |